UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolated bilateral macrostomia: literature review and case report

European journal of paediatric dentistry, 2023-02, Vol.24 (1), p.56

2023

Volltextzugriff (PDF)

Epidemiology of maxillofacial trauma in the elderly: A European multicenter study

Journal of stomatology, oral and maxillofacial surgery, 2020-09, Vol.121 (4), p.330-338

2020

Volltextzugriff (PDF)

Management of mandibular condylar fractures in patients with atrophic edentulous mandibles

Journal of stomatology, oral and maxillofacial surgery, 2020-06, Vol.121 (3), p.226-232

2020

Volltextzugriff (PDF)

MP-1.12: Circulating LDH Value in HRPC Patients After Ten Cycles of Chemotherapy: A Marker of Soft Tissue Lesions

Urology (Ridgewood, N.J.), 2008, Vol.72 (5), p.S64-S64

2008

Volltextzugriff (PDF)

Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer

Anticancer research, 1993-05, Vol.13 (3), p.769

Tarle, M

1993

Volltextzugriff (PDF)

Cross-correlation of serum chromogranin A, %-F-PSA and bone scans in prostate cancer diagnosis

Anticancer research, 2001-03, Vol.21 (2B), p.1363

2001

Volltextzugriff (PDF)

Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients

Anticancer research, 2001-03, Vol.21 (2B), p.1475

2001

Volltextzugriff (PDF)

Serum chromogranin A in monitoring metastatic prostate cancer patients

Anticancer research, 1999-11, Vol.19 (6C), p.5663

Tarle, M

1999

Volltextzugriff (PDF)

Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions

Anticancer research, 1988-07, Vol.8 (4), p.569

Tarle, M

1988

Volltextzugriff (PDF)

Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors

Anticancer research, 1993-01, Vol.13 (1), p.215

1993

Volltextzugriff (PDF)

BLOOD LDH AND CGA VALUES IN HRPC PATIENTS AFTER TEN CYCLES OF CHEMOTHERAPY: MARKERS OF SOFT TISSUE LESIONS AND OSTEOLYSIS

Anticancer research, 2008-10, Vol.28 (5C)

2008

Volltextzugriff (PDF)

Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients

Anticancer research, 2002-07, Vol.22 (4), p.2525

2002

Volltextzugriff (PDF)

Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor

Anticancer research, 1994-09, Vol.14 (5B), p.2151

1994

Volltextzugriff (PDF)

Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate

The Prostate, 1989, Vol.15 (3), p.211-219

1989

Volltextzugriff (PDF)

Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents

Urological research, 1991-02, Vol.19 (1), p.39-44

Tarle, M

1991

Volltextzugriff (PDF)

Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?

Anticancer research, 1997-05, Vol.17 (3A), p.1531

1997

Volltextzugriff (PDF)

Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH

Anticancer research, 1997-05, Vol.17 (3B), p.1671

1997

Volltextzugriff (PDF)

Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: Comparative study of a multiple tumor marker assay

The Prostate, 1991, Vol.19 (1), p.23-33

1991

Volltextzugriff (PDF)

Early diagnosis of prostate cancer in finasteride treated BPH patients

Anticancer research, 2003-01, Vol.23 (1B), p.693

2003

Volltextzugriff (PDF)

Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors

Progress in clinical and biological research, 1987, Vol.243B, p.521

1987

Volltextzugriff (PDF)

The uptake of radioiodinated 5 alpha-dihydrotestosterone by the prostate of intact and castrated rats

European journal of nuclear medicine, 1981-02, Vol.6 (2), p.79

1981

Volltextzugriff (PDF)

A more objective staging of advanced prostate cancer-routine recognition of malignant endocrine structures: The assessment of serum TPS, PSA, and NSE values

The Prostate, 1994-03, Vol.24 (3), p.143-148

1994

Volltextzugriff (PDF)

A new PTP parameter as potential predictor of prostate cancer response to therapy

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Vol.15 (2), p.225-227

Tarle, Marko

1988

Volltextzugriff (PDF)

Prolactin binding components in prostatic cancer tissue specimens obtained by TURP

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Vol.15 (6), p.713-716

Tarle, Marko

1988

Volltextzugriff (PDF)

The effect of prophylactic acetaminophen administration on reactions to DTP vaccination

American journal of diseases of children (1960), 1988-01, Vol.142 (1), p.62

1988

Volltextzugriff (PDF)

1 – 25 von 621

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(572)
Mit Volltextzugriff
(579)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Norwegisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Isolated bilateral macrostomia: literature review and case report

Epidemiology of maxillofacial trauma in the elderly: A European multicenter study

Management of mandibular condylar fractures in patients with atrophic edentulous mandibles

MP-1.12: Circulating LDH Value in HRPC Patients After Ten Cycles of Chemotherapy: A Marker of Soft Tissue Lesions

Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer

Cross-correlation of serum chromogranin A, %-F-PSA and bone scans in prostate cancer diagnosis

Oral estramustine therapy in serum chromogranin A-positive stage D3 prostate cancer patients

Serum chromogranin A in monitoring metastatic prostate cancer patients

Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions

Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors

BLOOD LDH AND CGA VALUES IN HRPC PATIENTS AFTER TEN CYCLES OF CHEMOTHERAPY: MARKERS OF SOFT TISSUE LESIONS AND OSTEOLYSIS

Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients

Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor

Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate

Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents

Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?

Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH

Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: Comparative study of a multiple tumor marker assay

Early diagnosis of prostate cancer in finasteride treated BPH patients

Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors

The uptake of radioiodinated 5 alpha-dihydrotestosterone by the prostate of intact and castrated rats

A more objective staging of advanced prostate cancer-routine recognition of malignant endocrine structures: The assessment of serum TPS, PSA, and NSE values

A new PTP parameter as potential predictor of prostate cancer response to therapy

Prolactin binding components in prostatic cancer tissue specimens obtained by TURP

The effect of prophylactic acetaminophen administration on reactions to DTP vaccination

Aktive Filter

Suchergebnisse filtern